Abstract
Diabetes mellitus (DM) is one of the predominant comorbidities among non-surviving COVID-19 patients. Diabetic patients exhibit a reduced immunogenic response to vaccines for infectious diseases in general. In Brazil, over 75% of type 2 diabetics are overweight or obese. Obesity itself affects the body's response to vaccines. The Butantan Institute produces two COVID-19 vaccines, the wide…